CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 41 enrolled
Drug / intervention
American Sign Language-Accessible Diabetes Education +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03980808
NCT03980808N/ACompleted
CompareCT.gov

American Sign Language-Accessible Diabetes Education

Georgia Institute of Technology·interventional·Posted Jun 10, 2019·Updated Jul 10, 2023

In Brief

A clinical study evaluating American Sign Language-Accessible Diabetes Education and Control Intervention for Diabetes and Deafness. Completed, enrolled 41 participants across 2 sites.

Detailed Summary

ASL-ADE will evaluate the efficacy of an ASL-interpreted diabetes educational intervention to the end of improving the health literacy of the target population and addressing their disparate health outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Deafness
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 10, 2019
Enrollment StartOct 29, 2020
Primary CompletionJan 26, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.1 years ago

Interventions

American Sign Language-Accessible Diabetes Educationbehavioral

Video-based ASL interpreted diabetes educational intervention (ASL-ADE), the content of which will be derived from diabetes health information regarding symptoms and risk factors that are published by the U.S. Centers for Diseases Control and Prevention (CDC) and the National Institute for Health (NIH) National Diabetes Education Program.

Control Interventionbehavioral

Non-health related video approximately the same length as ASL-ADE.